Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- SOWA-ICUIndependent statistical analysis of Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval,…
- Soy Protein and Breast Cancer Risk Reduction: Complete Statistical AnalysisIndependent statistical analysis of Soy Protein and Breast Cancer Risk Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00204477).
- Soy Protein/Effexor Hormone Therapy for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Soy Protein/Effexor Hormone Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00354432).
- SOYAIndependent statistical analysis of The Study of Soy Isoflavones in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052116).
- SP-RLBIndependent statistical analysis of The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SP0993Independent statistical analysis of Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older: primary endpoint results, effect estimate with…
- SPACERIndependent statistical analysis of The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SPAFIndependent statistical analysis of Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPANIndependent statistical analysis of A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in…
- Spanish-Language Smoking Cessation Trial: Complete Statistical AnalysisIndependent statistical analysis of Spanish-Language Smoking Cessation Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02945787).
- SPARCIndependent statistical analysis of Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SPARCIndependent statistical analysis of Sustaining Patient-centered Alcohol-related Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02675777).
- SPAREIndependent statistical analysis of Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPARKIndependent statistical analysis of Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPARKIndependent statistical analysis of Kuvan® in Phenylketonuria Patients Less Than 4 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01376908).
- SPARK Symptom Screening and Feedback to Providers: Complete Statistical AnalysisIndependent statistical analysis of SPARK Symptom Screening and Feedback to Providers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03593525).
- SPARK2Independent statistical analysis of Phase 2B Study Assessing Pain Relief After Replacement of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPARKLEIndependent statistical analysis of Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SPARTAIndependent statistical analysis of Spinery® A Novel Radio-Frequency Tumor Ablation Device for Spine Metastatic Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPARTANIndependent statistical analysis of Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPARTANIndependent statistical analysis of A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPARXIndependent statistical analysis of Study in Parkinson's Disease of Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01506479).
- SPDPIndependent statistical analysis of The Stanford Parkinson's Disease Plasma Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02968433).
- SPEACIndependent statistical analysis of Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma”: Complete Statistical AnalysisIndependent statistical analysis of Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma": primary endpoint results, effect estimate with confidence…
- Special Drug Use Surveillance of Vonoprazan for “Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use”: Complete Statistical AnalysisIndependent statistical analysis of Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use": primary endpoint results, effect estimate with confidence…
- Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01329380).
- Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Special Survey on Parkinson’s Disease (PD) Patients Without Concomitant Use of L-Dopa: Complete Statistical AnalysisIndependent statistical analysis of Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Specialized Pacing for Patients With Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Specialized Pacing for Patients With Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03361189).
- Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Specified Drug-Use Survey of Trelagliptin Tablets “Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease”: Complete Statistical AnalysisIndependent statistical analysis of Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease": primary endpoint results, effect…
- SPECSIndependent statistical analysis of SPECS: Safe Pediatric Euglycemia in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00443599).
- Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC: Complete Statistical AnalysisIndependent statistical analysis of Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Spectral Dynamics and Speech Understanding by Hearing Impaired People: Complete Statistical AnalysisIndependent statistical analysis of Spectral Dynamics and Speech Understanding by Hearing Impaired People: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01867515).
- SPECTREMIndependent statistical analysis of Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Spectroscopy Versus Standard Care in Cervical Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Spectroscopy Versus Standard Care in Cervical Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00529464).
- SPECTRUMIndependent statistical analysis of Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Speech Locator In-car Performance Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Speech Locator In-car Performance Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05054816).
- Speech Processing in Stuttering: Complete Statistical AnalysisIndependent statistical analysis of Speech Processing in Stuttering: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04929184).
- SPEEDIndependent statistical analysis of Patient Actor Training to Improve HIV Services for Adolescents in Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPEEDIndependent statistical analysis of Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPEEDIndependent statistical analysis of Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery: Complete Statistical AnalysisIndependent statistical analysis of Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02978690).